The InfiniTea GrimoireInfiniTea Apothecary

chapter of records

Research & Documentation

Administrative and supporting research materials. These are not botanical monographs.

Reading the research, not just the lore

This archive combines original research briefs and a second-pass source audit of all 58 botanicals. Its purpose is careful study, not a claim of clinical efficacy, commercial food approval, or authentication of a particular InfiniTea ingredient batch.

  1. Start with the botanical folio. Confirm the scientific name, plant part, preparation, and identity flags.
  2. Check the cited evidence. Distinguish cultural documentation, human clinical trials, laboratory findings, historical claims, and editorial sensory proposals.
  3. Use the audit before publication. Read the corrections and remaining limitations, then verify any claim proposed for packaging or public use against its primary source.

Four research records

The seven abbreviated, superseded monographs remain in the historical duplicate archive, outside the 58 canonical entries.

Evidence & provenance glossary

Botanical identity
The named taxon and plant part reported in the literature; this is not proof that a supplier's loose, cut, or powdered material matches it.
Traditional use
Evidence that a use is recorded in a named tradition or regulatory traditional-use category, not proof that an InfiniTea preparation has a clinical effect.
Energetics
A concept belonging to an identified historical or living knowledge system. It is not automatically a measurement of physiological heating, cooling, or therapeutic activity.
InfiniTea symbolism / Ritual Cue
Original contemporary interpretive writing. It must never be presented as ancestral, community-owned, or inherited ceremony.
Clinical evidence
Findings from studies of specific people, interventions, preparations, doses, and outcomes. They should not be generalized to every herb tea or extract.
Identity hold
A signal that species, market name, plant part, or processing needs further confirmation before any product decision.
Accession number
The Roman numeral at the top of each folio. It records the order in which a botanical entered the Grimoire and never changes, so new entries take the next number (LIX, LX and onward) and nothing is ever renumbered. The gallery itself is arranged A to Z.
Source-checked
A narrative editorial review of cited material within access limitations, not a systematic review, independent reproduction, or finished-product certification.

Items that still require real-world evidence

Source literature cannot authenticate supplier lots or validate finished beverage safety. Priority records include botanicals with name or species ambiguity, such as flor de tila, palo azul, skullcap, star anise, and blue lotus.

For a future sourcing record, capture scientific name, plant part, supplier, growing origin, lot and preparation method, along with any relevant authentication or analytical documentation. For a future beverage trial, separately document water, temperature, steep time, mass, sensory results, filtration, and applicable food-safety validation. Nothing in this archive substitutes for those steps.

Verification standards

Every folio's Verification box links here. These are the standards each folio was checked against.

Botanical identity: Scientific names checked against Kew Plants of the World Online where cited.

Evidence strength: Traditional use, regulatory monographs (EMA where available), and published reviews are distinguished. Clinical claims are limited to what primary sources support.

Language: Statements stronger than the supporting evidence have been noted or softened. Therapeutic effects are not asserted beyond traditional or preliminary findings.

Cultural attribution: Traditional practices are attributed to the communities that hold them; original InfiniTea interpretations are labeled as such.

Status: Source-checked research monograph for private use. Not a clinical recommendation or product claim.

Each folio's box adds its own record: the Phase II claim counts from the progress manifest, its number of distinct sources, its material status, and the result of the November 2026 re-reading of every Safety & Use citation.